Privia Health Group Stock (NASDAQ:PRVA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$22.47

52W Range

$18.77 - $26.51

50D Avg

$23.01

200D Avg

$22.90

Market Cap

$2.73B

Avg Vol (3M)

$789.72K

Beta

0.82

Div Yield

-

PRVA Company Profile


Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,140

IPO Date

Apr 28, 2021

Website

PRVA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Shared Savings$234.81M$179.20M$170.14M
Capitated Revenue$308.46M$212.99M$338.73M
Care Management Fee (PMPM)$73.14M$64.07M$50.52M
FFS-Administrative Services$137.02M$125.43M$113.15M
Other Revenue$9.18M$8.55M$8.50M
FFS-Patient Care$1.36B$1.15B$976.69M

Fiscal year ends in Dec 25 | Currency in USD

PRVA Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.12B$1.74B$1.66B
Operating Income$34.23M$16.98M$20.65M
Net Income$22.92B$14.38M$23.08M
EBITDA$53.84M$24.25M$27.18M
Basic EPS$0.19$0.12$0.20
Diluted EPS$0.18$0.11$0.19

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 26, 26 | 8:00 AM
Q3 25Nov 06, 25 | 8:00 AM
Q2 25Aug 07, 25 | 8:00 AM

Peer Comparison


TickerCompany
HTFLHeartflow, Inc. Common Stock
PBHPrestige Consumer Healthcare Inc.
ICUIICU Medical, Inc.
ATECAlphatec Holdings, Inc.
SUPNSupernus Pharmaceuticals, Inc.
NVSTEnvista Holdings Corp
TVTXTravere Therapeutics, Inc.
LIVNLivaNova PLC
ARQTArcutis Biotherapeutics, Inc.